AI449175 Activators
AI449175 activators encompass a diverse array of chemical compounds that enhance the functional activity of AI449175 through multiple distinct signaling pathways. Forskolin, by increasing cAMP levels, facilitates the activity of PKA, which may phosphorylate AI449175, augmenting its activity. PMA, as an activator of PKC, fosters phosphorylation cascades that could lead to the enhanced activity of AI449175. Calcium modulators like Ionomycin and A23187 elevate intracellular Ca2+ concentrations, paving the way for the activation of calcium-dependent kinases that potentially phosphorylate and activate AI449175. AI449175 activators are a compilation of chemical entities that indirectly facilitate the enhancement of AI449175's functional activity through a variety of signaling pathways. Forskolin, through the elevation of intracellular cAMP, activates PKA, which may phosphorylate AI449175, thereby boosting its activity. PMA, by triggering PKC, potentially initiates a phosphorylation cascade that culminates in the activation of AI449175.
Similarly, the calcium ionophores Ionomycin and A23187 elevate intracellular calcium levels, activating calcium-dependent kinases, which may subsequently phosphorylate and activate AI449175. Isoproterenol, acting on beta-adrenergic receptors, raises cAMP levels, thus fostering PKA activation and the potential phosphorylation and consequent activation of AI449175. Furthermore, Sildenafil and Zaprinast, by inhibiting PDE5 and increasing cellular cGMP levels, enhance PKG activity that could lead to the phosphorylation and subsequent activation of AI449175. LY294002, by inhibiting PI3K, may induce a compensatory response within the cell's signaling network that results in the activation of AI449175. Compounds like EGCG inhibit various kinases, potentially lifting negative regulation on AI449175 and leading to its activation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC). PKC phosphorylation pathways can result in the activation of AI449175 by phosphorylating it or associated regulatory proteins, thereby enhancing AI449175's functional activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular Ca2+ concentration. Elevated Ca2+ can activate calcium-dependent protein kinases, which may phosphorylate AI449175, leading to its enhanced functional activity. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is another calcium ionophore that raises intracellular calcium levels. The increase in calcium can stimulate calcium-dependent kinases that may target AI449175 for phosphorylation, enhancing its activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can alter the PI3K/Akt signaling pathway. This alteration can lead to compensatory mechanisms in cellular signaling that enhance the activity of AI449175 through indirect regulatory effects. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a polyphenol that has been shown to inhibit several protein kinases. This inhibition might reduce negative regulatory influences on AI449175, thereby increasing its activity through a relief of inhibition. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, leading to an increase in intracellular cAMP and cGMP levels. This broadly enhances PKA and PKG pathway activity, which may indirectly lead to the activation of AI449175. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast inhibits PDE5 and PDE6, increasing cGMP levels, which in turn may activate PKG. PKG can phosphorylate substrates that may include AI449175 or its associated proteins, potentially leading to the enhanced activity of AI449175. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that activates stress-activated protein kinases (such as JNK). This activation can lead to the phosphorylation of transcription factors that indirectly increase the activity of AI449175 by stress response. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
8-Bromo-cAMP is a cAMP analog that activates PKA. Activated PKA can phosphorylate various proteins including AI449175, potentially leading to an increase in its functional activity. | ||||||